Markets › LSE › 0J2O.L

Halozyme Therapeutics, Inc.

LSE:0J2O.LHealthcare

——At close · Market cap — · Next earnings Mon 2 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	83.8%	81.6%	72.4%	67.9%	77.3%	78.1%	—	—
Operating margin	53.9%	62.2%	43.8%	41.0%	54.3%	58.4%	58.4%	+0.0 pts
Net margin	48.2%	90.8%	30.6%	34.0%	43.7%	22.7%	22.7%	+0.0 pts
EBITDA margin	57.2%	58.4%	47.8%	54.5%	64.7%	64.8%	—	—
Return on equity	85.5%	204.5%	119.0%	336.0%	122.1%	649.2%	649.2%	+0.0 pts
Return on assets	22.3%	36.5%	11.0%	16.2%	20.5%	11.7%	11.7%	+0.0 pts
Return on capital employed	91.0%	27.9%	16.9%	21.0%	27.2%	32.2%	—	—
Debt / equity	2.7×	4.5×	8.9×	18.2×	4.2×	45.1×	45.1×	+0.0%
Debt / assets	69.1%	79.4%	81.8%	88.0%	71.0%	81.1%	—	—
Interest coverage	7.1×	36.7×	17.1×	18.1×	30.5×	45.0×	—	—
Current ratio	1.3×	7.9×	5.7×	6.6×	7.8×	4.7×	4.7×	+0.0%
Quick ratio	1.2×	7.4×	4.9×	5.5×	6.8×	3.7×	—	—
Cash ratio	0.4×	1.0×	1.8×	1.1×	0.8×	0.8×	0.8×	+0.0%
Asset turnover	0.5×	0.4×	0.4×	0.5×	0.5×	0.5×	—	—
Inventory turnover	0.7×	1.5×	1.8×	2.1×	1.6×	1.7×	—	—
Receivables turnover	2.7×	4.9×	2.9×	3.5×	3.3×	3.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—